When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn and Samsung Biologics inks deal to manufacture leronlimab
CytoDyn Inc
CytoDyn (OTCQB:CYDY) has entered into an agreement with Samsung BioLogics for the clinical and commercial manufacturing of $1B worth of leronlimab (PRO 140).
More news on: CytoDyn Inc., Healthcare stocks news,